Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / App Notes / 2020 / Be Sure, Today and Tomorrow—LC-MS in Clinical Research

Be Sure, Today and Tomorrow—LC-MS in Clinical Research

06/16/2020

Share

 

The fabulous scientific advances witnessed in the world of analytical sciences have had a profound influence on the health, comfort and welfare of mankind. However, one can question if there is enough understanding and appreciation of the intensive study in clinical science where the main focus is usually on the discovery and not in the requirements that made the discovery possible (Sr., 1993).

 

 

Mass spectrometry (MS) has been a known technology for almost one hundred years, from the time when its basic principles were first described by Nobel laureate Sir Joseph John Thomson in 1897 (JJ 1897, JJ 1913). Despite some very early research on the use of MS for respiratory gas analysis in the 1950s (KT and P, 1957), the majority of early applications of MS in clinical diagnosis go back to the early 1970s with the application of Gas Chromatography (GC) coupled to MS for determination of a variety of biologically significant molecules.

Because GC requires a certain level of analyte volatility, and since most biologically active molecules are polar, thermolabile, and involatile, elaborate extraction and derivatization protocols had to be devised to implement GCMS useful enough for the analysis of clinically relevant analytes and samples. To make sample analysis less difficult by MS, a significant amount of R&D.

 

 

>> Download the Full White Paper as a PDF

 

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

OncoKDM Lite: Improving TSO500 data interpretation accuracy from VCF files in oncology routine practice

March 2, 2020

Deep Proteomic Profiling of Subregions within the Tumor Microenvironment Using Novel MALDI Guided SpatialOMx®

March 13, 2020

ClearLLab 10C Panel Markers and how they are combined

May 5, 2020

ClearLLab Control Cells - A Process Control for ClearLLab 10C Application

May 5, 2020

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.